Stay updated on Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page no longer lists 'Multiple myeloma' as a topic and removes related topics including MedlinePlus Genetics. This reduces explicit disease labeling and related topic references on the study page.
    Difference
    0.1%
    Check dated 2025-12-12T07:22:43.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision: v3.3.2 appears to be a minor backend update with no changes to study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-28T02:17:55.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Added note that the Publications section is auto-filled from PubMed and may not reflect the study content, and updated the revision tag to v3.3.1.
    Difference
    0.0%
    Check dated 2025-11-20T22:12:51.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    A government funding/operating status notice has been removed from the page, a non-substantive content update that does not affect study details or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-13T15:34:29.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Multiple myeloma is now listed as a topic on the page, and a related topic link to MedlinePlus Genetics was added. These additions provide clearer disease context and access to patient education resources.
    Difference
    0.2%
    Check dated 2025-10-30T08:58:27.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Term updated from 'Plasma cell myeloma' (v3.0.2) to 'Multiple myeloma' (v3.2.0) indicating a terminology refresh and version bump.
    Difference
    0.1%
    Check dated 2025-10-01T02:52:56.000Z thumbnail image

Stay in the know with updates to Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial page.